DOA
GWPH

D'Orazio & Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

D'Orazio & Associates’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-75
Closed -$9K – 350
2017
Q1 		$9K Hold
75
– – ﹤0.01% 226
2016
Q4 		$8K Hold
75
– – ﹤0.01% 218
2016
Q3 		$9K Hold
75
– – ﹤0.01% 204
2016
Q2 		$7K Hold
75
– – ﹤0.01% 235
2016
Q1 		$5K Buy
+75
New +$4.12K ﹤0.01% 250

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

D'Orazio & Associates's GWPH Position: Q2 2017 in Review

D'Orazio & Associates sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2017, closing a stake of 75 shares — an estimated $9K sold.

D'Orazio & Associates first reported a position in GWPH in Q1 2016 and held it in 5 quarters. The position peaked at $9K in Q1 2017. 170 funds tracked by Wall St. Rank hold GWPH as of Q2 2017.

  • D'Orazio & Associates reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2017 after selling out during the quarter.
  • D'Orazio & Associates sold 75 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2017, an estimated $9K.
  • D'Orazio & Associates first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2016 and held it in 5 quarters.
  • D'Orazio & Associates's GW Pharmaceuticals Plc American Depositary Shares position peaked at $9K in Q1 2017.
  • 170 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2017.

Based on D'Orazio & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.